Woven Data, Inc. was founded in 2017, bringing together experts in the Pharma, Business Intelligence, and Technology fields. We provide market access managed services, analytics, and data integration solutions to pharmaceutical manufacturers, delivered via a fully integrated cloud-based data and analytics platform. Our team prides ourselves on empowering clients to derive insights, make data-driven decisions, and maximize the value of their portfolio and commercial strategies throughout all phases of their product lifecycle. We are headquartered in San Francisco, CA.
Lisa leads Sales and Business Development at Woven Data. Prior to joining the company, Lisa spent 16 years at ValueCentric/IQVIA as the VP of Customer Account Management and Key Account Director. Prior to ValueCentric, Lisa was the Senior VP of Industry Relations and led the development of industry standards for EDI guidelines including 852, 867, and 850, and led supply chain logistics initiatives at the Healthcare Distribution Management Association (HDMA). Lisa holds a BS in Radio/TV Communications from Radford University.
Scott leads Client Services at Woven Data. His expertise is in Pharma Market Access and Government Programs. Before co-founding Woven Data, Scott was the VP of Market Access and Commercial Operations at Covis Pharma, and prior to there he worked with numerous manufacturers at CIS and Alliance Life Sciences. Scott earned his BS in Accounting from the Pennsylvania State University.
Andrei leads Analytics and Business Intelligence at Woven Data. Before co-founding Woven Data, he spent more than a few years wrestling data for Fortune 500 companies, by building Data Warehousing and Data Science solutions. Andrei holds an MBA from Stanford, and an MS from the Belarusian State University.
Sergei leads Product Development and is the CEO of Woven Data. Prior to co-founding the company, he was building products at Twitter, and held Product, Marketing, and Engineering roles at a number of tech startups. Sergei earned his Masters Degrees in Management and Engineering from Stanford, and a BS from MIT.
Lynne is highly respected for her deep expertise in government contracting, pricing, and compliance. Prior to retiring from consulting, she ran her own successful consulting practice for over 20 years, and helped more than 60 emerging and established pharmaceutical companies comply with federally mandated contract and price reporting requirements. She started her career at Syntex Corporation and Roche.
Mary is an independent consultant focusing on commercialization strategies for emerging companies and therapies, with projects spanning the development, acquisition, and commercialization phases of pharma companies. Clients rely on Mary's expertise to establish and test a product's value proposition and pricing sensitivity, identify barriers to product access, and develop a roadmap for market access — including payer coverage and reimbursement, channel access, coding and policy changes, as well as applying for and obtaining billing codes. Mary has over 30 years in the pharmaceutical industry.